Sarepta Therapeutics Regains NASDAQ Compliance

Sarepta Therapeutics, Inc. SRPT announced today that it received a letter from the listing qualifications department staff of The NASDAQ Stock Market LLC, stating that the Company has regained compliance with NASDAQ's minimum $1.00 per share bid price requirement. The letter received noted that for 10 consecutive business days, from July 12, 2012 to July 25, 2012, the closing bid price of the Company's common stock was $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5450(a)(1) and the matter is closed.